Expression, localization, and function of the carnitine transporter octn2 (slc22a5) in human placenta.
about
OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamiliesLongitudinal Metabolomic Profiling of Amino Acids and Lipids across Healthy PregnancyL-carnitine supplementation of sows during pregnancy improves the suckling behaviour of their offspring.Set-base dynamical parameter estimation and model invalidation for biochemical reaction networks.Xenobiotic, bile acid, and cholesterol transporters: function and regulation.High doses of ursodeoxycholic acid up-regulate the expression of placental breast cancer resistance protein in patients affected by intrahepatic cholestasis of pregnancyRemote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis.Interleukin-18 Down-Regulates Multidrug Resistance-Associated Protein 2 Expression through Farnesoid X Receptor Associated with Nuclear Factor Kappa B and Yin Yang 1 in Human Hepatoma HepG2 Cells.Placental transporter localization and expression in the Human: the importance of species, sex, and gestational age differences†.Active transport across the human placenta: impact on drug efficacy and toxicity.Excretion of biliary compounds during intrauterine life.Drug transporters in the human blood-placental barrier.Influence of l-carnitine on metabolism and performance of sows.Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues.Genetic polymorphisms in placental transporters: implications for fetal drug exposure to oral antidiabetic agents.Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure.Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity.Placental control of drug delivery.Expression of Organic Anion Transporting Polypeptide 1A2 in Red Blood Cells and Its Potential Impact on Antimalarial Therapy.Transport of L-carnitine in human corneal and conjunctival epithelial cells.Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway.Carnitine status of pregnant women: effect of carnitine supplementation and correlation between iron status and plasma carnitine concentration.The effect of the mode of delivery on the maternal-neonatal carnitine blood levels and antioxidant status.Evaluation of carnitine deficit in very low birth weight preterm newborns small for their gestational age.Determination of carnitine ester patterns during the second half of pregnancy, at delivery, and in neonatal cord blood by tandem mass spectrometry: complex and dynamic involvement of carnitine in the intermediary metabolism.Evaluating effects of L-carnitine on human bone-marrow-derived mesenchymal stem cells.A Non-Targeted LC-MS Profiling Reveals Elevated Levels of Carnitine Precursors and Trimethylated Compounds in the Cord Plasma of Pre-Eclamptic Infants
P2860
Q27001267-F28C554F-70A3-4CA5-B29D-1FED019D4335Q28551938-3C2C918D-6FC8-4163-81FC-FA4750A2C12AQ30319985-273B0891-A782-441E-ACD0-5D0AFA2A7777Q33586851-ABC015FF-F614-4599-AA9F-5FFE9EBF399EQ33714593-C877D85A-334A-4352-9AD1-53DDE6E7FC95Q34745175-F5BEA24B-D0D2-4B14-B3C7-74CC139792C2Q34865706-BE145F7B-D01A-4F85-BEAC-25EADE4F5784Q35751457-990B9585-6B2B-4315-B619-EE50201F721EQ36322293-CB7084A5-9B5B-4986-B006-99FBA876B014Q36545029-4B4D0768-EF0A-4ADE-B39E-BA161995F634Q37122394-608E0A92-062F-46D5-A703-F28EDBD7A94CQ37395889-61DCBFCF-B514-4D1F-AA29-082E64D44410Q37524540-38D0E2C4-4BA1-4DAA-A481-3A4F4F0FECAFQ37604379-D6DCC9DD-0F8D-420A-A060-9769BB9687B2Q37830057-297E4FB6-2A6D-49CD-9922-1373B2276B91Q38044958-6136470C-FE18-483B-B794-D1FDB14C2284Q38613161-31842C81-BBAD-4B37-BDE2-AE4453427E35Q38928337-53FE8DFF-579F-4EEC-B008-C7BC76129E24Q39509379-FF4B135D-4177-4AE4-9246-AF592C2BDC66Q39636436-850CDC31-9D52-4076-BBF0-C2688CEA4FA5Q41996128-5279D102-600C-4756-B7AF-E30D2DD18BBAQ43457109-2F92AE96-EF2A-4644-8F5A-AE08C6C37C6BQ46328313-1B15E317-B255-4640-BC94-FBBFB8C46B7CQ47399848-4716D2AA-3E96-40F0-8E5E-528B7ECC85F8Q51914176-FE2594F9-855B-4646-9018-F7242AF2ED08Q52907071-3F03950D-37B7-4EAA-B67A-0D3E21204405Q57050288-45C68194-4361-472E-B51E-FC447BC6F71D
P2860
Expression, localization, and function of the carnitine transporter octn2 (slc22a5) in human placenta.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Expression, localization, and ...... 2 (slc22a5) in human placenta.
@en
Expression, localization, and ...... 2 (slc22a5) in human placenta.
@nl
type
label
Expression, localization, and ...... 2 (slc22a5) in human placenta.
@en
Expression, localization, and ...... 2 (slc22a5) in human placenta.
@nl
prefLabel
Expression, localization, and ...... 2 (slc22a5) in human placenta.
@en
Expression, localization, and ...... 2 (slc22a5) in human placenta.
@nl
P2093
P356
P1476
Expression, localization, and ...... n2 (slc22a5) in human placenta
@en
P2093
Christoph Fusch
Damaris Präger
Gabriele Jedlitschky
Heyo K Kroemer
Katrin Draber
Klaus-Uwe Möritz
Knud Linnemann
Markus Grube
P356
10.1124/DMD.104.001560
P577
2004-10-14T00:00:00Z